Back
Northrop Grumman Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
45
NOC
Northrop Grumman
Last Price:
$458.64
Seasonality Move:
5.09%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
45
Northrop Grumman (NOC)
is a Sell
Is Northrop Grumman a Buy, Sell or Hold?
-
The current Northrop Grumman [NOC] share price is $458.69. The Score for NOC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NOC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NOC Stock Price Chart
What is Northrop Grumman's stock price today?
-
The Northrop Grumman share price today is $458.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NOC is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $40.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
NOC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.03 | Sell |
Relative Strength Index (14 RSI): | 36.87 | Sell |
Chaikin Money Flow: | -168060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (462.89 - 479.95) | Sell |
Bollinger Bands (100): | (481.49 - 528.79) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -2576687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.5 - 57.26) | Sell |
Bollinger Bands (100): | (51.08 - 57.64) | Sell |
NOC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 462.51 | Sell |
20-day SMA: | 469.31 | Sell |
50-day SMA: | 487.42 | Sell |
200-day SMA: | 482.16 | Sell |
8-day EMA: | 462.03 | Sell |
20-day EMA: | 469.05 | Sell |
50-day EMA: | 483.02 | Sell |
200-day EMA: | 484.77 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.44 | Sell |
20-day SMA: | 52.35 | Sell |
50-day SMA: | 55.3 | Sell |
200-day SMA: | 51.01 | Sell |
8-day EMA: | 48.54 | Sell |
20-day EMA: | 51.52 | Sell |
50-day EMA: | 53.69 | Sell |
200-day EMA: | 49.87 | Sell |
Northrop Grumman Earnings Growth & NOC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $1.76 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Northrop Grumman Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |